Literature DB >> 12999769

The metabolism of epinephrine containing isotopic carbon. II.

R W SCHAYER, R L SMILEY, E H KAPLAN.   

Abstract

Entities:  

Keywords:  EPINEPHRINE/metabolism

Mesh：

Substances：

Year:  1952        PMID： 12999769

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  8 in total

1.  Metabolism of noradrenaline in the human.

Authors:  M GOODALL; N KIRSHNER; L ROSEN
Journal:  J Clin Invest       Date:  1959-04       Impact factor: 14.808

2.  Metabolism of 7-H3-epinephrine-d-bitartrate in normal young men.

Authors:  E H LABROSSE; J AXELROD; I J KOPIN; S S KETY
Journal:  J Clin Invest       Date:  1961-02       Impact factor: 14.808

3.  The mechanism of the irreversible inhibition of rat-liver monoamine oxidase by iproniazid (marsilid).

Authors:  A N DAVISON
Journal:  Biochem J       Date:  1957-10       Impact factor: 3.857

4.  Increase of formation of methylamine and formaldehyde in vivo after administration of nicotine and the potential cytotoxicity.

Authors:  P H Yu
Journal:  Neurochem Res       Date:  1998-09       Impact factor: 3.996

5.  The urinary excretion of adrenaline and noradrenaline by rats under various experimental conditions.

Authors:  T B CRAWFORD; W LAW
Journal:  Br J Pharmacol Chemother       Date:  1958-03

6.  Comparison of phenelzine and geometric isomers of its active metabolite, β-phenylethylidenehydrazine, on rat brain levels of amino acids, biogenic amine neurotransmitters and methylamine.

Authors:  Dmitriy Matveychuk; Emerson Nunes; Nasir Ullah; Carlos A Velázquez-Martinez; Erin M MacKenzie; Glen B Baker
Journal:  J Neural Transm (Vienna)       Date:  2013-02-08       Impact factor: 3.575

7.  Implication for functions of the ectopic adipocyte copper amine oxidase (AOC3) from purified enzyme and cell-based kinetic studies.

Authors:  Sam H Shen; Diana L Wertz; Judith P Klinman
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

Review 8.  SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease.

Authors:  Mercedes Unzeta; Mar Hernàndez-Guillamon; Ping Sun; Montse Solé
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.